Skip to main navigation menu Skip to main content Skip to site footer

Original article

Vol. 154 No. 2 (2024)

An economic evaluation of an early palliative care intervention among patients with advanced cancer

  • Maud Maessen
  • Monica C. Fliedner
  • Brigitta Gahl
  • Marina Maier
  • Daniel M. Aebersold
  • Susanne Zwahlen
  • Steffen Eychmüller
DOI
https://doi.org/10.57187/s.3591
Cite this as:
Swiss Med Wkly. 2024;154:3591
Published
16.02.2024

Summary

BACKGROUND: Early integration of palliative care into oncology care has shown positive effects on patient symptoms and quality of life. It may also reduce health care costs. However given the heterogeneity of settings and interventions and the lack of information on the minimally effective dose for influencing care utilisation and costs, it remains uncertain whether early palliative care reduces costs.

OBJECTIVES: We sought to determine whether an early palliative care intervention integrated in usual oncology care in a Swiss hospital setting reduced utilisation and costs of health care in the last month of life when compared with usual oncology care alone.

METHODS: We performed a cost-consequences analysis alongside a multicentre trial. We extracted costs from administrative health insurance data and health care utilisation from family caregiver surveys to compare two study arms: usual oncology care and usual oncology care plus the palliative care intervention. The intervention consisted of a single-structured, multiprofessional conversation with the patient about symptoms, end-of-life decisions, network building and support for carers (SENS). The early palliative care intervention was performed within 16 weeks of the diagnosis of a tumour stage not amenable or responsive to curative treatment.

RESULTS: We included 58 participants with advanced cancer in our economic evaluation study. Median overall health care costs in the last month of life were 7892 Swiss Francs (CHF) (interquartile range: CHF 5637–13,489) in the intervention arm and CHF 8492 [CHF 5411–12,012] in the control arm. The average total intervention treatment cost CHF 380 per patient. Integrating an early palliative care intervention into usual oncology care showed no significant difference in health care utilisation or overall health care costs between intervention and control arms (p = 0.98).

CONCLUSION: Although early palliative care is often presented as a cost-reducing care service, we could not show a significant effect of the SENS intervention on health care utilisation and costs in the last month of life. However, it may be that the intervention was not intensive enough, the timeframe too short or the study population too small for measurable effects. Patients appreciated the intervention. Single-structured early palliative care interventions are easy to implement in clinical practice and present low treatment costs. Further research about the economic impact of early palliative care should focus on extracting large, detailed cost databases showing potential shifts in cost and cost-effectiveness.

Clinical Trials. gov Identifier: NCT01983956

References

  1. Reeve R, Srasuebkul P, Langton JM, Haas M, Viney R, Pearson SA; EOL-CC study authors. Health care use and costs at the end of life: a comparison of elderly Australian decedents with and without a cancer history. BMC Palliat Care. 2017 Jun;17(1):1. 10.1186/s12904-017-0213-0 DOI: https://doi.org/10.1186/s12904-017-0213-0
  2. von Wyl V, Telser H, Weber A, Fischer B, Beck K. Cost trajectories from the final life year reveal intensity of end-of-life care and can help to guide palliative care interventions. BMJ Support Palliat Care. 2018 Sep;8(3):325–34. 10.1136/bmjspcare-2014-000784 DOI: https://doi.org/10.1136/bmjspcare-2014-000784
  3. Sobanski P, Krajnik M, Beattie JM. Integrating the complementary skills of palliative care and cardiology to develop care models supporting the needs of those with advanced heart failure. Curr Opin Support Palliat Care. 2016 Mar;10(1):8–10. 10.1097/SPC.0000000000000197 DOI: https://doi.org/10.1097/SPC.0000000000000197
  4. Mathews J, Hannon B, Zimmermann C. Models of Integration of Specialized Palliative Care with Oncology. Curr Treat Options Oncol. 2021 Apr;22(5):44. 10.1007/s11864-021-00836-1 DOI: https://doi.org/10.1007/s11864-021-00836-1
  5. Huo B, Song Y, Chang L, Tan B. Effects of early palliative care on patients with incurable cancer: A meta-analysis and systematic review. Eur J Cancer Care (Engl). 2022 Nov;31(6):e13620. 10.1111/ecc.13620 DOI: https://doi.org/10.1111/ecc.13620
  6. Ferrell BR, Temel JS, Temin S, Alesi ER, Balboni TA, Basch EM, et al. Integration of Palliative Care Into Standard Oncology Care: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol. 2017 Jan;35(1):96–112. 10.1200/JCO.2016.70.1474 DOI: https://doi.org/10.1200/JCO.2016.70.1474
  7. Jordan K, Aapro M, Kaasa S, Ripamonti CI, Scotté F, Strasser F, et al. European Society for Medical Oncology (ESMO) position paper on supportive and palliative care. Ann Oncol. 2018 Jan;29(1):36–43. 10.1093/annonc/mdx757 DOI: https://doi.org/10.1093/annonc/mdx757
  8. Ma J, Chi S, Buettner B, Pollard K, Muir M, Kolekar C, et al. Early Palliative Care Consultation in the Medical ICU: A Cluster Randomized Crossover Trial. Crit Care Med. 2019 Dec;47(12):1707–15. 10.1097/CCM.0000000000004016 DOI: https://doi.org/10.1097/CCM.0000000000004016
  9. Morrison RS, Dietrich J, Ladwig S, Quill T, Sacco J, Tangeman J, et al. Palliative care consultation teams cut hospital costs for Medicaid beneficiaries. Health Aff (Millwood). 2011 Mar;30(3):454–63. 10.1377/hlthaff.2010.0929 DOI: https://doi.org/10.1377/hlthaff.2010.0929
  10. Greer JA, Tramontano AC, McMahon PM, Pirl WF, Jackson VA, El-Jawahri A, et al. Cost Analysis of a Randomized Trial of Early Palliative Care in Patients with Metastatic Nonsmall-Cell Lung Cancer. J Palliat Med. 2016 Aug;19(8):842–8. 10.1089/jpm.2015.0476 DOI: https://doi.org/10.1089/jpm.2015.0476
  11. Eychmüller S, Zwahlen S, Fliedner MC, Jüni P, Aebersold DM, Aujesky D, et al. Single early palliative care intervention added to usual oncology care for patients with advanced cancer: A randomized controlled trial (SENS Trial). Palliat Med. 2021 Jun;35(6):1108–17. 10.1177/02692163211005340 DOI: https://doi.org/10.1177/02692163211005340
  12. Fliedner M, Zambrano S, Schols JM, Bakitas M, Lohrmann C, Halfens RJ, et al. An early palliative care intervention can be confronting but reassuring: A qualitative study on the experiences of patients with advanced cancer. Palliat Med. 2019 Jul;33(7):783–92. 10.1177/0269216319847884 DOI: https://doi.org/10.1177/0269216319847884
  13. Eychmüller S. [SENS is making sense - on the way to an innovative approach to structure Palliative Care problems]. Ther Umsch. 2012 Feb;69(2):87–90. DOI: https://doi.org/10.1024/0040-5930/a000256
  14. Fliedner MC, Mitchell G, Bueche D, Mettler M, Schols JM, Eychmueller S. Development and Use of the ‘SENS’-Structure to Proactively Identify Care Needs in Early Palliative Care-An Innovative Approach. Healthcare (Basel). 2019 Feb;7(1):32. 10.3390/healthcare7010032 DOI: https://doi.org/10.3390/healthcare7010032
  15. de Kock I, Mirhosseini M, Lau F, Thai V, Downing M, Quan H, et al. Conversion of Karnofsky Performance Status (KPS) and Eastern Cooperative Oncology Group Performance Status (ECOG) to Palliative Performance Scale (PPS), and the interchangeability of PPS and KPS in prognostic tools. J Palliat Care. 2013;29(3):163–9. 10.1177/082585971302900305 DOI: https://doi.org/10.1177/082585971302900305
  16. Garrison LP, Jr., Pauly MV, Willke RJ, Neumann PJ. An Overview of Value, Perspective, and Decision Context-A Health Economics Approach: An ISPOR Special Task Force Report [2]. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 2018;21(2):124-30. DOI: https://doi.org/10.1016/j.jval.2017.12.006
  17. Hearn J, Higginson IJ; Palliative Care Core Audit Project Advisory Group. Development and validation of a core outcome measure for palliative care: the palliative care outcome scale. Qual Health Care. 1999 Dec;8(4):219–27. 10.1136/qshc.8.4.219 DOI: https://doi.org/10.1136/qshc.8.4.219
  18. Cella D, Hahn EA, Dineen K. Meaningful change in cancer-specific quality of life scores: differences between improvement and worsening. Qual Life Res. 2002 May;11(3):207–21. 10.1023/A:1015276414526
  19. Lubben J, Blozik E, Gillmann G, Iliffe S, von Renteln Kruse W, Beck JC, et al. Performance of an abbreviated version of the Lubben Social Network Scale among three European community-dwelling older adult populations. Gerontologist. 2006 Aug;46(4):503–13. 10.1093/geront/46.4.503 DOI: https://doi.org/10.1093/geront/46.4.503
  20. Hagemann M, Zambrano SC, Bütikofer L, Bergmann A, Voigt K, Eychmüller S. Which Cost Components Influence the Cost of Palliative Care in the Last Hospitalization? A Retrospective Analysis of Palliative Care Versus Usual Care at a Swiss University Hospital. J Pain Symptom Manage. 2020 Jan;59(1):20–29.e9. 10.1016/j.jpainsymman.2019.08.026 DOI: https://doi.org/10.1016/j.jpainsymman.2019.08.026
  21. May P, Normand C. Analyzing the Impact of Palliative Care Interventions on Cost of Hospitalization: Practical Guidance for Choice of Dependent Variable. J Pain Symptom Manage. 2016 Jul;52(1):100–6. 10.1016/j.jpainsymman.2016.01.009 DOI: https://doi.org/10.1016/j.jpainsymman.2016.01.009
  22. Brinkman-Stoppelenburg A, Polinder S, Olij BF, van den Berg B, Gunnink N, Hendriks MP, et al. The association between palliative care team consultation and hospital costs for patients with advanced cancer: an observational study in 12 Dutch hospitals. Eur J Cancer Care (Engl). 2020 May;29(3):e13198. 10.1111/ecc.13198 DOI: https://doi.org/10.1111/ecc.13198
  23. May P, Normand C, Cassel JB, Del Fabbro E, Fine RL, Menz R, et al. Economics of Palliative Care for Hospitalized Adults With Serious Illness: A Meta-analysis. JAMA Intern Med. 2018 Jun;178(6):820–9. 10.1001/jamainternmed.2018.0750 DOI: https://doi.org/10.1001/jamainternmed.2018.0750
  24. Scibetta C, Kerr K, Mcguire J, Rabow MW. The Costs of Waiting: Implications of the Timing of Palliative Care Consultation among a Cohort of Decedents at a Comprehensive Cancer Center. J Palliat Med. 2016 Jan;19(1):69–75. 10.1089/jpm.2015.0119 DOI: https://doi.org/10.1089/jpm.2015.0119
  25. Panczak R, Luta X, Maessen M, Stuck AE, Berlin C, Schmidlin K, et al. Regional Variation of Cost of Care in the Last 12 Months of Life in Switzerland: Small-Area Analysis Using Insurance Claims Data. Med Care. 2016.
  26. Kalseth J, Halvorsen T. Health and care service utilisation and cost over the life-span: a descriptive analysis of population data. BMC Health Serv Res. 2020 May;20(1):435. 10.1186/s12913-020-05295-2 DOI: https://doi.org/10.1186/s12913-020-05295-2
  27. May P, Garrido MM, Cassel JB, Kelley AS, Meier DE, Normand C, et al. Prospective Cohort Study of Hospital Palliative Care Teams for Inpatients With Advanced Cancer: Earlier Consultation Is Associated With Larger Cost-Saving Effect. J Clin Oncol. 2015 Sep;33(25):2745–52. 10.1200/JCO.2014.60.2334 DOI: https://doi.org/10.1200/JCO.2014.60.2334
  28. May P, Garrido MM, Cassel JB, Kelley AS, Meier DE, Normand C, et al. Cost analysis of a prospective multi-site cohort study of palliative care consultation teams for adults with advanced cancer: where do cost-savings come from? Palliat Med. 2017 Apr;31(4):378–86. 10.1177/0269216317690098 DOI: https://doi.org/10.1177/0269216317690098
  29. Davis MP, Temel JS, Balboni T, Glare P. A review of the trials which examine early integration of outpatient and home palliative care for patients with serious illnesses. Ann Palliat Med. 2015 Jul;4(3):99–121.
  30. Petrou S, Gray A. Economic evaluation alongside randomised controlled trials: design, conduct, analysis, and reporting. BMJ. 2011 Apr;342 apr07 2:d1548. 10.1136/bmj.d1548 DOI: https://doi.org/10.1136/bmj.d1548
  31. Panczak R, Luta X, Maessen M. Regional Variation of Cost of Care in the Last 12 Months of Life in Switzerland: Small-area Analysis Using Insurance Claims Data. Volume 55. LIPPINCOTT WILLIAMS & WILKINS; 2017. DOI: https://doi.org/10.1097/MLR.0000000000000634
  32. Matter-Walstra KW, Achermann R, Rapold R, Klingbiel D, Bordoni A, Dehler S, et al. Days spent in acute care hospitals at the end of life of cancer patients in four Swiss cantons: a retrospective database study (SAKK 89/09). Eur J Cancer Care (Engl). 2016. DOI: https://doi.org/10.1111/ecc.12453
  33. Bähler C, Rapold R, Signorell A, Reich O, Panczak R, Blozik E. Regional differences in healthcare costs at the end of life: an observational study using Swiss insurance claims data. Int J Public Health. 2020 Jul;65(6):969–79. 10.1007/s00038-020-01428-w DOI: https://doi.org/10.1007/s00038-020-01428-w
  34. Bevölkerungsbefragung Palliative Care 2017. Bern: Bundesamt für Gesundheit BAG 2018.

Most read articles by the same author(s)